SynthesisThe journal of headache and pain2024

Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis.

Wattakorn Laohapiboolrattana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.